Amoxicillin resistance with β-lactamase production in Helicobacter pylori

European Journal of Clinical Investigation

Volumn 39, Issue 9, 2009, Pages 807-812

  Tseng, Y S ^a   Wu, D C ^b,c   Chang, C Y ^a   Kuo, C H ^b,c   Yang, Y C ^b   Jan, C M ^b,c   Su, Y C ^b,c   Kuo, F C ^d   Chang, L L ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d I SHOU UNIVERSITY   (Taiwan)

Author keywords

lactamase; Amoxicillin resistance; BlaTEM 1; H. pylori

Indexed keywords

AMOXICILLIN; BETA LACTAMASE; NITROCEFIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DOT HYBRIDIZATION; EFFUSION; ENZYME ACTIVITY; GENE SEQUENCE; HELICOBACTER PYLORI; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

AMOXICILLIN; BETA-LACTAMASES; DRUG RESISTANCE, MICROBIAL; GENE EXPRESSION REGULATION, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 68349150382     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02166.x     Document Type: Article

References (31)

1. Sanders MK, Peura DA. Helicobacter pylori-associated diseases. Curr Gastroenterol Rep 2002 4 : 48 54.
2. Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis 2006 6 : 699 709.
3. Sugimoto M, Furuta T, Shirai N, Kodaira C, Nishino M, Yamade M et al. Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics. Expert Opin Pharmacother 2007 8 : 2701 17.
4. Dore MP, Osato MS, Realdi G, Mura I, Graham DY, Sepulveda AR. Amoxycillin tolerance in Helicobacter pylori. J Antimicrob Chemother 1999 43 : 47 54.
5. Ecclissato C, Marchioretto MA, Mendonca S, Godoy AP, Guersoni RA, Deguer M et al. Increased primary resistance to recommended antibiotics negatively affects Helicobacter pylori eradication. Helicobacter 2002 7 : 53 9.
6. Mendonca S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M et al. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter 2000 5 : 79 83.
7. Jacoby GA, Archer GL. New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med 1991 324 : 601 12.
8. Nikaido H. Multidrug efflux pumps of gram-negative bacteria. J Bacteriol 1996 178 : 5853 9.
9. Gerrits MM, Godoy AP, Kuipers EJ, Ribeiro ML, Stoof J, Mendonca S et al. Multiple mutations in or adjacent to the conserved penicillin-binding protein motifs of the penicillin-binding protein 1A confer amoxicillin resistance to Helicobacter pylori. Helicobacter 2006 11 : 181 7.
10. Okamoto T, Yoshiyama H, Nakazawa T, Park ID, Chang MW, Yanai H et al. A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori. J Antimicrob Chemother 2002 50 : 849 56.
11. DeLoney CR, Schiller NL. Characterization of an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Antimicrob Agents Chemother 2000 44 : 3368 73.
12. Co EM, Schiller NL. Resistance mechanisms in an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Antimicrob Agents Chemother 2006 50 : 4174 6.
13. Dore MP, Graham DY, Sepulveda AR, Realdi G, Osato MS. Sensitivity of amoxicillin-resistant Helicobacter pylori to other penicillins. Antimicrob Agents Chemother 1999 43 : 1803 4.
14. Horii T, Kimura T, Sato-Kawamura K, Nada T, Shibayama K, Ohta M. Beta-Lactamase inhibitors have antibacterial activities against Helicobacter pylori. J Infect Chemother 1999 5 : 206 7.
15. Horii T, Mase K, Suzuki Y, Kimura T, Ohta M, Maekawa M et al. Antibacterial activities of beta-lactamase inhibitors associated with morphological changes of cell wall in Helicobacter pylori. Helicobacter 2002 7 : 39 45.
16. Ojetti V, Migneco A, Zocco MA, Nista EC, Gasbarrini G, Gasbarrini A. Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate. J Intern Med 2004 255 : 125 9.
17. Vcev A, Vukovic D, Ivandic A, Vceva A, Dmitrovic B, Kovacic D et al. Another therapeutic schedule in eradication of Helicobacter pylori. Acta Med Croatica 1997 51 : 95 9.
18. Glupczynski Y, Megraud F, Lopez-Brea M, Andersen LP. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2001 20 : 820 3.
19. Hu CT, Wu CC, Lin CY, Cheng CC, Su SC, Tseng YH et al. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan. J Gastroenterol Hepatol 2007 22 : 720 3.
20. Cao P, McClain MS, Forsyth MH, Cover TL. Extracellular release of antigenic proteins by Helicobacter pylori. Infect Immun 1998 66 : 2984 6.
21. Mittl PR, Luthy L, Hunziker P, Grutter MG. The cysteine-rich protein A from Helicobacter pylori is a beta-lactamase. J Biol Chem 2000 275 : 17693 9.
22. DeLoney CR, Schiller NL. Competition of various beta-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology. Antimicrob Agents Chemother 1999 43 : 2702 9.
23. Gerrits MM, Schuijffel D, van Zwet AA, Kuipers EJ, Vandenbroucke-Grauls CM, Kusters JG. Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori. Antimicrob Agents Chemother 2002 46 : 2229 33.
24. Kwon DH, Dore MP, Kim JJ, Kato M, Lee M, Wu JY et al. High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob Agents Chemother 2003 47 : 2169 78.
25. Paul R, Postius S, Melchers K, Schafer KP. Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin. Antimicrob Agents Chemother 2001 45 : 962 5.
26. Rimbara E, Noguchi N, Kawai T, Sasatsu M. Correlation between substitutions in penicillin-binding protein 1 and amoxicillin resistance in Helicobacter pylori. Microbiol Immunol 2007 51 : 939 44.
27. Rimbara E, Noguchi N, Kawai T, Sasatsu M. Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori. J Antimicrob Chemother 2008 61 : 995 8.
28. van Amsterdam K, Bart A, van der Ende A. A Helicobacter pylori TolC efflux pump confers resistance to metronidazole. Antimicrob Agents Chemother 2005 49 : 1477 82.
29. Bina JE, Alm RA, Uria-Nickelsen M, Thomas SR, Trust TJ, Hancock RE. Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob Agents Chemother 2000 44 : 248 54.
30. Kutschke A, de Jonge BL. Compound efflux in Helicobacter pylori. Antimicrob Agents Chemother 2005 49 : 3009 10.
31. Kuipers EJ, Israel DA, Kusters JG, Blaser MJ. Evidence for a conjugation-like mechanism of DNA transfer in Helicobacter pylori. J Bacteriol 1998 180 : 2901 5.